CD19-targeting CAR T Cells for B Cell Lymphoma

NCT02547948 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

B Cell Lymphoma

Interventions

BIOLOGICAL: CD19-targeting CAR T Cells infusion

Sponsor

Fuda Cancer Hospital, Guangzhou